ABSTRACT. A full-length cDNA clone of an equine carbonic anhydrase (CA)-VI was obtained from the equine parotid gland. The cDNA sequence was 1338 bp long and was predicted to encode a 319 amino acid polypeptide with a putative signal peptide of 18 amino acids. The deduced amino acid sequence of mature CA-VI showed the similarity of 70% to those of other mammalians reported. Westernblot analysis using anti-horse CA-VI peptide detected the single band in parotid gland, and the band reduced its size by treatment with Nglycosidase F. Additionally, CA-VI protein expression was confirmed in submandicular gland and weakly in liver. In contrast, RT-PCR analysis revealed signals in the digestive tract including duodenum, jejunum, ileum, cecum and colon as well as the salivary glands. In addition, certain signals were detected in testis, thyroid gland and liver, but not in nerve tissue, skeletal muscle, spleen or lymph node.
Carbonic anhydrase (CA; EC 4.2.1.1) is a zinc containing metalloenzyme that catalyzes the reversible hydration of carbon dioxide [2] . In mammals, at least 14 distinct isoenzymes of CA have been identified [6] . Among other isozymes, CA-VI is a unique secretory type that was discovered in the ovine parotid gland and saliva [4] , and it was first purified by Feldstein and Silverman from rat saliva [3] . CA-VI is well known to be involved in regulating pH of saliva and protecting the upper alimentary canal against excess acidity [15] . It is also demonstrated that CA-VI is secreted by seromucous tracheobronchial glands, the serous epithelial cells of the trachea and bronchi, and by the Clara cells of the bronchium [13] . The presence of CA-VI in the airway surface liquid indicated that it protects mucous not only in the gastrointestinal tract but also in the respiratory tract as a pH neutralizer. In addition, it was suggested that CA-VI plays an important role in normal growth and development of infant alimentary tract from the evidence of its high concentration in colostrums and growth-supporting role in the taste buds [7, 11] . Gustin, a salivary secretory protein identical to CA-VI, has been demonstrated to protect the taste receptor cells from apoptosis [18] . Although a lot information on CA-VI is accumulating, little is known on that of equine family. Interestingly, there were some differences of expressional pattern in alimentary tracts between species [10, 15] . Until now, several mammalian CA6 cDNAs have been cloned successfully [1, 8, 14, 16] , though that of equine remains to be determined. Here in this study, we investigated and determined the nucleotide sequence of equine CA6 cDNA and examined its expression in various organs as the first step of exploring the physiological roles of CA-VI in equine. All experiments were performed according to the guidelines of The Laboratory Animal Care Committee of Azabu University, and complied in The Japanese Animal Welfare Guide. Total RNA was isolated from the parotid gland of a male 6-year-old thoroughbred using an RNA extraction solution (Isogen, Nippon Gene, Tokyo). Degenerate primers used for the amplification of a partial equine CA6 cDNA was prepared as described previously [1, 9] . RT-PCR amplification was performed with the total RNA and these degenerate primers employing a SuperScript first cDNA system kit (Invitrogen Japan, Tokyo) using AmpliTaq DNA polymerase (Applied Biosystems Japan, Tokyo). The RT-PCR products were verified to be a single expected band of approximately 500 bp by agarose gel electrophoresis. The band was excised from the agarose gel and purified using NucleoTrap Gel Extraction kit (Nippon Genetics, Tokyo). The extracted and purified DNA was cloned into a pCR II-TOPO cloning vector (Invitrogen Japan, Tokyo) and sequenced using a Thermo sequenase fluorescent labelled primer cycle sequencing kit (GE Healthcare UK Ltd. Amersham, UK) and a DSQ2000L DNA sequencer (Shimadzu, Kyoto). The nucleotide sequence comprising 451 bp showed high similarities of 80.3% to bovine CA6 cDNA sequences.
In order to determine the 3' and 5' regions of cDNA, RACE methods were carried out using a SMART RACE cDNA amplification kit using Takara Ex Taq hot start version (Takara Bio Inc, Otsu) and a set of equine CA6 genespecific primers (GSP: see Table 1 ). An obtained nucleotide sequence (accession number AB354636) corresponding to a full-length equine CA6 cDNA was 1338 bp in length and contained an entire open reading frame of 960 bp, encoding equine CA6 of 319 amino acids (Fig. 1 ). The deduced amino acid sequence of mature CA6 showed a similarity of 70% to those of other mammalians including human, cattle, sheep and dog, while the sequence of 90 amino acid in the C-terminal region varied among mammalians (30%). A typical polyadenylation signal was found in the 3'-untranslated region. The deduced 319 amino acids included a signal peptide (18 amino acids) typical of most secreted proteins where the region was enriched with hydrophobic residues as like other mammalians, and the peptide is one residue longer than that of canine [14] . Therefore, the predicted mature protein was speculated to consist of 301 amino acids. The amino acid sequence of the deduced equine mature CA-VI was 10 residues longer than that of human CA-VI, and 2, 4 and 6 residues shorter than those of dog, bovine and sheep CA-VI, respectively. Two cysteine residues (amino acid positions 22 and 204), which are known to form intra-molecular disulfide bonds in sheep CA-VI [4] , are conserved and three histidine residues (amino acid positions 91, 93 and 118) responsible for zinc-binding were also found. In addition, two potential N-glycosylation sites (Asn-X-Thr/Ser) were detected; one of these (amino acid positions 236-238, Asn-Lys-Thr) is known to be glycosylated in sheep CA-VI, and another site (amino acid positions 40-42, Asn-Pro-Ser) is in common with human, sheep, bovine and mouse, although this site does not correspond to the known glycosylation site and is unlikely to be involved in N-glycosylation [8] .
In order to examine the expression of CA6 mRNA in various organs of a horse, we performed RT-PCR using newly designed primers specific to equine CA6 (Table 1) . Total RNA samples were extracted from the major salivary glands, digestive tracts and several tissues of a healthy horse, and RT-PCR was performed using the Super Script One-Step RT-PCR with Platium Taq (Invitrogen Japan, Tokyo), according to the manufacturer's instructions. RT-PCR conditions were as follows: 55C 30 min, 94C 2 min and 30 cycles of three steps; 94C 15 sec 58C 20 sec and 68C 20 sec. Figure 3 showed the detection of equine CA6 mRNA in various tissues from horse. CA6 mRNA (A) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (B). The discrete bands of 354 bp in length, which were derived from CA6 mRNA, were observed in all of the major salivary glands and digestive tract including stomach, duodenum, jejunum, ileum, cecum and colon, whereas no bands were generated from specimens of the nerve tissue (spinal cord), skeletal muscle, spleen or lymph node. There were some differences in CA6 expression between species. In dog, CA6 was not detected in the lower alimentary tract including stomach, jejunum, ileum and colon in RT-PCR study [15] . In equine alimentary tract, CA-VI expression was confirmed in both small and large intestine as indicated Fig. 3 . Therefore, it can be speculated that herbivore possess CA-VI secretion including the lower alimentary tract [10] . Interestingly, a certain signal was observed in the testis, thyroid gland and liver. To our knowledge, there is no report on CA-VI expression in testis, and exact function of CA6 in this tissue remains unclear in this stage. To investigate the horse CA-VI protein expression in various horse tissues, anti-horse CA-VI rabbit serum was prepared by the peptide antigen designed according to the center region of horse sequence (C-NIQDMLPKDLRYYYSYQGS; residues 180-198). Simply, peptide conjugated with keyhole limpet hemocyanin (KLH) was purchased from the laboratory of Operon Biotechnology Co., Ltd (Tokyo, Japan). Anti-horse Fig. 2 . Comparison of the amino acid sequences of mature CA-VI in the horse, dog, human, cattle and sheep. Multiple sequence alignments were performed using the Genetyx programme (ver 8). Asterisks and dots indicate identical residues and conservative substitution, respectively. Cys residues are indicated by diamonds and His residues by triangles. These are likely to form an intra-molecular disulfide bond and to bind to zinc, respectively. The potential glycosylation sites are indicated by stars.
CA-VI serum was purified by passage over an affinity column of the peptide antigen. Crude extracts from each tissue was obtained by homogenized with addition of x1 Cell Lysis buffer (Promega KK, Osaka). The protein bands in the SDS-PAGE gel were transferred to a polyvinylidene difluoride membrane, and then the membrane was treated with the primary antibody (rabbit anti-horse CA-VI,  5,000), and then the secondary antibody (anti-rabbit IgG (H+L) goat IgG Fab' HRP,  20,000, Seikagaku Corp., Tokyo). The CA-VI protein was detected with an ECL chemiluminescence detection system (GE Healthcare UK Ltd. Amersham, UK) and exposed to an x-ray film. For deglycosylation study, the sample was treated with N-glycosidase F (Roche Diagnostic KK, Tokyo). Figure 4 showed Westernblot analysis of horse CA-VI expression in crude extract of parotid gland with (+) or without (-) treatment of PNGase F at 37C for 6 hr. The single band at 35 kDa was detected in parotid gland, and reduced its size by addition of N-glycosidase F, which confirmed that horse CA-VI was glycosilated protein. It was reported that molec- Fig. 3 . Detection of equine CA6 mRNA in various tissues from horse. CA6 mRNA (A) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (B) were examined by RT-PCR techniques using primers specific to each cDNA indicated in Table 1 . RT-PCR conditions were as follows: 55C 30 min, 94C 2 min and 30 cycles of three steps; 94C 15 sec 58C 20 sec and 68C 20 sec. ular size of cattle was 42 kDa (10) . The difference size between horse and cattle was considered due to amount of glycosilation between species. Figure 5 showed Westernblot analysis of horse CA-VI expression in crude extract of various tissues. In contract, there is not any signal in other tissues except in parotid and submandicular gland and weakly in liver. This discrepancy between RT-PCR and Western blot analysis may due to sensitivity of each system. The significance of CA-VI expression in these tissues is under investigation by immuno-histochemistry.
In conclusion, the deduced amino acid sequence (mature polypeptides) of the horse cDNA demonstrated high similarity to those of various mammalian species and the putative functional sites were well conserved except for Cterminal. Westernblot analysis using anti-horse CA-VI peptide detected the single band in parotid gland, and the band reduced its size by treatment with N-glycosidase F. Additionally, CA-VI protein expression was confirmed in submandicular gland and weakly in liver. In contrast, RT-PCR analysis revealed CA-VI expression in the digestive tract including duodenum, jejunum, ileum, cecum and colon as well as the salivary glands. In addition, certain signals were detected in testis, thyroid gland and liver, but not in nerve tissue, skeletal muscle, spleen or lymph node. The discrepancy CA6 detection between RT-PCR and Westernblot may due to the sensitivity of each system.
